These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28632990)

  • 21. Die-off ratio correlates with increased TNF-α:IL-10 ratio and decreased IVF success rates correctable with humira.
    Winger EE; Reed JL; Ashoush S; El-Toukhy T; Taranissi M
    Am J Reprod Immunol; 2012 Nov; 68(5):428-37. PubMed ID: 22845061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of seasonal variations on in vitro fertilization and fresh/frozen embryo transfer: a retrospective study.
    Xiao Y; Wang M; Liu K
    Arch Gynecol Obstet; 2018 Sep; 298(3):649-654. PubMed ID: 29971557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does supraphysiologic estradiol level during IVF have any effect on oocyte/embryo quality? A sibling embryo cohort analysis of fresh and subsequent frozen embryo transfer.
    Sarkar P; Gandhi A; Plosker S; Ying Y; Mayer J; Imudia AN
    Minerva Ginecol; 2018 Dec; 70(6):716-723. PubMed ID: 30264951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of growth of 4-cell embryos on the day of transfer in fresh IVF-ET cycles.
    Pereira N; Brauer AA; Melnick AP; Lekovich JP; Spandorfer SD
    J Assist Reprod Genet; 2015 Jun; 32(6):939-43. PubMed ID: 25925346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the outcome of frozen-thawed embryo transfer.
    Veleva Z; Orava M; Nuojua-Huttunen S; Tapanainen JS; Martikainen H
    Hum Reprod; 2013 Sep; 28(9):2425-31. PubMed ID: 23756705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of elevated basal follicle-stimulating hormone on the quantity and quality of oocytes and embryos and pregnancy outcomes in young women].
    Chen SL; Luo YQ; Xia R; Chen X; Shi XY; Zheng HY; Wang LL; Wu YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):777-81. PubMed ID: 21602123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial.
    Doody KJ; Broome EJ; Doody KM
    J Assist Reprod Genet; 2016 Apr; 33(4):495-500. PubMed ID: 26843390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objective way to support embryo transfer: a probabilistic decision.
    Gianaroli L; Magli MC; Gambardella L; Giusti A; Grugnetti C; Corani G
    Hum Reprod; 2013 May; 28(5):1210-20. PubMed ID: 23462389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
    Niu ZH; Feng Y; Zhang AJ; Zhang HQ; Sun YJ; Lu XW
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates.
    Strawn EY; Roesler M; Rinke M; Aiman EJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1623-8. PubMed ID: 10871488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
    Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of human embryo cultivation in a classic CO2 incubator with 20% oxygen versus benchtop incubator with 5% oxygen on live births: the randomized prospective trial.
    Gelo N; Kirinec G; Baldani DP; Vrčić H; Ježek D; Milošević M; Stanić P
    Zygote; 2019 Jun; 27(3):131-136. PubMed ID: 31072414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
    Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
    Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
    Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
    Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.